[ad_1]
Doctors raised the alarm last March about a possible link between blood pressure-regulating medications being taken by millions of patients worldwide and the emerging Corona virus.
The doctors’ concern was caused by animal studies that concluded that pressure medications can increase the secretion levels of a protein called ACE2 in the body.
The Corona virus binds to this protein when it invades human cells, and therefore increases the risk of coronavirus infection in people with high blood pressure, according to the British newspaper “Daily Mail”.
But 3 new studies have denied this relationship between the protein and the coronavirus, and have found that common blood pressure medications don’t put people at greater risk of contracting the coronavirus.
All three studies, published in the prestigious New England Journal of Medicine, found that taking blood pressure medication “makes no difference” to the risk or severity of coronavirus infection.
Some people with high blood pressure or type 1 or second diabetes take these medications, which increase the amount of ACE2 protein in their cells, to control their disease.
The newspaper noted that doctors in the UK gave prescriptions for pressure tablets about 65 million times last year, and the National Health Service has cost more than £ 100 million.
It is estimated that around 10 percent of people in the UK, or about 6.6 million, regularly take pressure tablets, especially those with diabetes or high blood pressure.
");
//}, 3000);
}
});
//$(window).bind('scroll ');
$ (window) .scroll (function () {
if (alreadyLoaded_facebookConnect == false) {
alreadyLoaded_facebookConnect = true;
// $ (window) .unbind ('scroll');
// console.log ("loaded offset");
(function (d, s, id) {
var js, fjs = d.getElementsByTagName (s)[0];
if (d.getElementById (id)) return;
js = d.createElement (s); js.id = id;
js.async = true;
js._https = true;
js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322";
fjs.parentNode.insertBefore (js, fjs);
} (document, 'script', 'facebook-jssdk'));
// pre_loader ();
// $ (window) .unbind ('mousemove');
// setTimeout (function () {
// $ ('# boxTwitter'). html ("Tweets from @tayyar_org");
//}, 3000);
var scriptTag = document.createElement ("script");
scriptTag.type = "text / javascript"
scriptTag.src = "https://news.google.com/scripts/social.js";
scriptTag.async = true;
document.getElementsByTagName ("head")[0].appendChild (scriptTag);
(function () {
$ .getScript ("https://news.google.com/scripts/social.js", function () {});
});
}
});
//$(window).load(function () {
// setTimeout (function () {
// // add the returned content to a newly created script tag
// var se = document.createElement ('script');
// se.type = "text / javascript";
// //se.async = true;
// se.text = "setTimeout (function () {pre_loader ();}, 5000);";
// document.getElementsByTagName ('body')[0].appendChild (se);
//}, 5000);
//});
[ad_2]
